In March 2021, a report was published accusing Ormat Technologies (ORA) of systematic intentional corruption. On it, $ORA fell 1.1%, losi...

In October 2021, Omeros (OMER) announced that FDA found deficiencies in Company’s license application for a drug candidate, not expected ...

In early May 2022, Novartis (NVS) announced suspension of production at sites in Italy and the US due to quality concerns. Then, in late ...

In October 2023, NatWest (NWG) admitted serious failings related to closing Nigel Farage’s account, UK Financial Conduct Authority openin...

In June 2021, a Japanese newspaper reported Mitsubishi Electric (MIELY) admitting faking test data for AC equipment supplied to train com...

In December 2021, the SEC charged Medallion (MFIN) and its President and COO, “with illegally engaging in two schemes in an effort to rev...

In July and October 2023, MaxLinear (MXL) disclosed sharp Y2Y drop in revenue for Q2’23 and Q3’23 respectively, as well as revised downwa...

$LNC stockholder filed a claim vs. Lincoln for overstating financial results and business prospects. On November 2, 2022, $LNC fell 33.2%...

In January 2022, the NYT article questioned the accuracy of certain prenatal tests offered by Labcorp (LH). On it, $LH fell 5%, losing $1...

$ASRT stockholder filed a claim vs. Assertio, its CEO & CFO for overstating the true potential of the Spectrum deal, which led to shareho...

The SEC alleged that TruCrowd failed to conduct due diligence in the crowdfunding offerings, exposing investors to fraud. Specifically,...

In June 2023, Wiley revealed a 6% revenue decrease after the suspension of the publishing program with subpar material. On it, $WLY fell...

In May 2023, a newspaper reported the FBI-assisted execution of a DHS search warrant at the JinkoSolar site. On it, $JKS fell 8.3%, losi...

In October 2022, Instil announced pausing enrollment in ITIL-168 ongoing clinical trials due to drug shortage. On it, $TIL fell 37.1%, l...

Investors in Maison Solutions' stocks have initiated a claim against $MSS and its executives, alleging misleading IPO statements. In Dec...

In April, Infosys’s Q4’ 22 financial results missed consensus estimates, CEO warned of uncertain environment. On it, $INFY fell 9.8%, los...

In Oct, Hormel updated its strategic priorities long-term forecast, reducing projected sales growth and EPS . On it, $HRL fell 9.8%, losi...